NCT00564018View on ClinicalTrials.gov

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

NATerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

April 30, 2011

Conditions
Type 1 Diabetes
Interventions
DRUG

Insulin detemir

Dosage adjusted to meet age-specific glycemic goals throughout course of study.

DRUG

Glargine

Dosage to be adjusted to meet age-specific glycemic goals throughout course of study.

DRUG

NPH

Dosage to be adjusted to meet age specific glycemic goals throughout course of study.

Trial Locations (1)

75235

Children's Medical Center, Dallas

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT00564018 - Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH | Biotech Hunter | Biotech Hunter